Li Jin, Zhang Bin, Xu Rongchen, Wang Bingxin, Hao Wenjun, Zhang Xiaoxiao
Department of Stomatology, The Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Department of Stomatology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Ann Transl Med. 2022 Jul;10(14):792. doi: 10.21037/atm-22-2974.
To investigate the identification of spalt-like transcription factor 4 (SALL4) in oral squamous cell carcinoma (OSCC).
Recombinant cells loaded with miRNA expression cells were used to transform Tca8113 cells. Simple Tca8113 cells were used as the control group. We detected SALL4 messenger RNA (mRNA) before and after transfection by reverse transcription polymerase chain reaction (RT-PCR) and protein immunoblotting (western blot) A and protein expression. A dual luciferase reporter system was used to verify the targeted regulation of SALL4 and identify miRNA-S to test the effect of miRNA related to SALL4 regulation on the invasion and metastatic ability of Tca8113 cells.
The expression of SALL4 mRNA in Tca8113 cells was higher than that in the downregulated and control groups, respectively (P<0.05); there was no difference in Tca8113 cells between the upregulated and downregulated groups (P>0.05). Dual luciferase reporter system showed that the identified miRNA was miRNA-S; there were no differences in migration and invasion of Tca8113 cells between the up- and down-regulated groups (P>0.05).
In human OSCC, SALL4 regulation-related miRNAs are poorly expressed and can inhibit the invasion and metastasis of tumor cells, which is expected to become a new therapeutic target for OSCC.
探讨口腔鳞状细胞癌(OSCC)中锌指样转录因子4(SALL4)的鉴定。
用装载有miRNA表达细胞的重组细胞转染Tca8113细胞。单纯Tca8113细胞作为对照组。通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法(western blot)检测转染前后SALL4信使核糖核酸(mRNA)和蛋白质表达。采用双荧光素酶报告系统验证SALL4的靶向调控并鉴定miRNA-S,以检测与SALL4调控相关的miRNA对Tca8113细胞侵袭和转移能力的影响。
Tca8113细胞中SALL4 mRNA的表达分别高于下调组和对照组(P<0.05);上调组和下调组的Tca8113细胞之间无差异(P>0.05)。双荧光素酶报告系统显示鉴定出的miRNA为miRNA-S;上调组和下调组的Tca8113细胞迁移和侵袭能力无差异(P>0.05)。
在人类OSCC中,与SALL4调控相关的miRNA表达较低,可抑制肿瘤细胞的侵袭和转移,有望成为OSCC的新治疗靶点。